Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Cancer Treatment and Research|October 9, 2021
Acute Promyelocytic Leukemia: Update on Risk Stratification and Treatment PracticesAmandeep Salhotra, Matthew MeiHematology/Oncology Clinics of North America|January 3, 2026
Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel TherapiesAnnie Xiao, Matthew MeiClinical Lymphoma, Myeloma & Leukemia|December 14, 2017
How to Approach a Hodgkin Lymphoma Patient With Relapse After Autologous SCT: Allogeneic SCTMatthew Mei, Robert ChenCancers|April 12, 2022
Autologous Stem Cell Transplantation in Hodgkin Lymphoma-Latest Advances in the Era of Novel TherapiesYazeed Samara, Matthew MeiJournal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
The role of transplant in multiple myelomaMatthew Mei, George SomloBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2013
Management of relapsed or refractory hodgkin lymphoma with second-generation antibody-drug conjugates: focus on brentuximab vedotinMatthew Mei, Sandra Thomas, Robert ChenCurrent Hematologic Malignancy Reports|January 7, 2021
Emerging Therapies in Relapsed and Refractory Hodgkin Lymphoma: What Comes Next After Brentuximab Vedotin and PD-1 Inhibition?Tamer Othman, Alex Herrera, Matthew MeiAmerican Journal of Hematology|December 1, 2018
Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: Update on clinical trial data and practical considerations for useMatthew Mei, Ibrahim Aldoss, Guido Marcucci, et al.Cancer Treatment and Research|October 9, 2021
Current and Emerging Therapies for Acute Myeloid LeukemiaBrian Ball, Matthew Mei, Salman Otoukesh, et al.Neurochemical Research|September 28, 2005
P38 activation mediates amyloid-beta cytotoxicityXiongwei Zhu, Matthew Mei, Hyoung-Gon Lee, et al.Pageof 8